Objective: May-Thurner syndrome (MTS) is an anatomic stenotic variation associated with deep vein thrombosis (DVT) of the left leg. The classical DVT treatment strategy is medical treatment without thrombus removal. This study was performed to assess the clinical outcomes of the combination of AngioJet™ rheolytic thrombectomy and stenting for treatment of MTS-related DVT.
Methods: We conducted a retrospective cohort study of patients treated for MTS-related DVT from January 2017 to June 2020 at a single institution.
Results: Fourteen patients (nine women) underwent AngioJet™ rheolytic thrombectomy for MTS-related DVT during the study period. The median DVT onset time was 8 days (interquartile range (IQR), 3-21 days). The median procedure time was 130 minutes (IQR, 91-189 minutes), and the median hospital stay was 7 days (IQR, 5-26 days). One patient had a residual thrombus and occluded iliac stent and underwent adjuvant catheter-directed thrombolysis for revascularization. The primary patency rate for the iliac stent was 92.9% at 12 months.
Conclusion: Concomitant AngioJet™ rheolytic thrombectomy and stenting of MTS-induced lesions may be beneficial for patients with MTS-related DVT.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168862 | PMC |
| http://dx.doi.org/10.1177/03000605221100134 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In-hospital outcomes of acute aortic occlusion treated by endovascular intervention: A single center study.
Vascular
December 2024
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Harapan Kita National Cardiovascular Center, Jakarta, Indonesia.
Background: Endovascular intervention by means of thrombolysis is emerging as a promising management of Acute Aortic Occlusion (AAO). This study aims to evaluate the outcomes of endovascular thrombectomy for AAO cases in a single-center tertiary hospital in Indonesia.
Methods: We review retrospectively AAO patients treated by Rheolytic thrombectomy ± stenting or TEVAR at our referral center from 2011 to 2024.
The rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries.
Int Angiol
November 2024
Department of Vascular and Endovascular Surgery, St. Franziskus Hospital, Muenster, Germany.
Background: The aim of this study is to evaluate the safety and feasibility of the AngioJet™ device in the endovascular treatment of visceral ischemia with stenotic or occlusive lesions.
Methods: Retrospective analysis of patients treated for visceral artery occlusion with thrombectomy using the AngioJet™ (Boston Scientific, MA, USA). Inclusion criteria: patients with stenotic or occluding lesion in visceral arteries including renal and mesenteric arteries, who received endovascular treatment with AngioJet™.
Factors related to acute kidney injury after AngioJet rheolytic thrombectomy.
Acta Radiol
November 2024
Department of Radiology, College of Medicine, Jeonbuk National University, Jeonju, Republic of Korea.
Background: AngioJet rheolytic thrombectomy is associated with a higher risk of acute kidney injury due to its potential for inducing mechanical harm and intravascular hemolysis. However, previous studies have focused on a single disease entity.
Purpose: To identify predictors associated with acute kidney injury after AngioJet rheolytic thrombectomy across a range of disease entities.
Article Synopsis
- Acute pulmonary embolism (PE) poses a significant risk of death in patients with active cancer; this study examines how cancer affects treatment choices and outcomes.
- Out of 872 examined PE patients, 14.8% had active malignancy, with varying treatment approaches and poorer long-term outcomes for those with cancer.
- Despite higher mortality rates and challenges, catheter-based treatments show promise for effectively managing PE in cancer patients while maintaining manageable bleeding risks.
Management and outcomes of venous thoracic outlet decompression: A transition to the infraclavicular approach.
J Vasc Surg Venous Lymphat Disord
November 2024
Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA. Electronic address:
Article Synopsis
- Venous thoracic outlet syndrome (vTOS) involves the compression of the subclavian vein, leading to potential vein thrombosis, with treatment primarily focusing on thoracic outlet decompression and rib resection.
- A study conducted on 76 patients treated for vTOS from 2007 to 2022 revealed that the majority presented with swelling and had a high incidence of deep vein thrombosis, often requiring anticoagulation before surgery.
- Most surgeries involved rib resection through the infraclavicular approach, with a low rate of complications and no perioperative mortality, although some patients did experience bleeding complications post-surgery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!